TNXP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Tonix Pharmaceuticals Holding Corp (TNXP) is not a strong buy at this moment for a beginner investor with a long-term perspective. While insider buying and revenue growth are positive indicators, the technical indicators are neutral to bearish, and the financials show significant net losses and declining EPS. Additionally, no strong trading signals or news catalysts are present to justify immediate action.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 31.106, and moving averages are converging, showing no clear trend. Support is at 12.504, and resistance is at 14.284. The stock is trading near support levels, but no strong upward momentum is evident.
Insider buying has increased significantly by 1801.93% over the last month, and revenue growth in the latest quarter was 108.75% YoY.
The company reported a significant net loss of -46.91M in Q4 2025, and EPS declined by -59.67% YoY. No recent news or congress trading data is available. Technical indicators are neutral to bearish, and no strong trading signals are present.
In Q4 2025, revenue increased by 108.75% YoY to $5.39M, and gross margin improved to 80.37%. However, net income remained negative at -$46.91M, and EPS dropped significantly to -3.96, down -59.67% YoY.
No recent analyst ratings or price target changes are available for TNXP.
